Clemency Stephenson
Overview
Explore the profile of Clemency Stephenson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fendler A, Au L, Shepherd S, Byrne F, Cerrone M, Boos L, et al.
Nat Cancer
. 2022 Feb;
2(12):1321-1337.
PMID: 35121900
Patients with cancer have higher COVID-19 morbidity and mortality. Here we present the prospective CAPTURE study, integrating longitudinal immune profiling with clinical annotation. Of 357 patients with cancer, 118 were...
2.
Fendler A, Shepherd S, Au L, Wilkinson K, Wu M, Byrne F, et al.
Nat Cancer
. 2022 Feb;
2(12):1305-1320.
PMID: 35121899
Coronavirus disease 2019 (COVID-19) antiviral response in a pan-tumor immune monitoring (CAPTURE) ( NCT03226886 ) is a prospective cohort study of COVID-19 immunity in patients with cancer. Here we evaluated...
3.
Fendler A, Shepherd S, Au L, Wilkinson K, Wu M, Byrne F, et al.
Nat Cancer
. 2021 Dec;
2:1321-1337.
PMID: 34950880
CAPTURE (NCT03226886) is a prospective cohort study of COVID-19 immunity in patients with cancer. Here we evaluated 585 patients following administration of two doses of BNT162b2 or AZD1222 vaccines, administered...
4.
Fendler A, Au L, Shepherd S, Byrne F, Cerrone M, Boos L, et al.
Res Sq
. 2021 Sep;
PMID: 34580668
Patients with cancer have higher COVID-19 morbidity and mortality. Here we present the prospective CAPTURE study (NCT03226886) integrating longitudinal immune profiling with clinical annotation. Of 357 patients with cancer, 118...
5.
De Stefano V, Ghirardi A, Masciulli A, Carobbio A, Palandri F, Vianelli N, et al.
Blood
. 2019 Dec;
135(5):381-386.
PMID: 31869407
Patients with Philadelphia-negative myeloproliferative neoplasm (MPN) are prone to the development of second cancers, but the factors associated with these events have been poorly explored. In an international nested case-control...
6.
Marchetti M, Ghirardi A, Masciulli A, Carobbio A, Palandri F, Vianelli N, et al.
Am J Hematol
. 2019 Dec;
95(3):295-301.
PMID: 31816122
One out of ten patients with Philadelphia-negative myeloproliferative neoplasms (MPN) develop a second cancer (SC): in such patients we aimed at assessing the survival impact of SC itself and of...
7.
Barbui T, Ghirardi A, Masciulli A, Carobbio A, Palandri F, Vianelli N, et al.
Leukemia
. 2019 May;
33(8):1996-2005.
PMID: 31142846
We conducted a large international nested case-control study including 1881 patients with Philadelphia-negative myeloproliferative neoplasms (MPN). Cases (n = 647) were patients with second cancer (SC: carcinoma, non-melanoma skin cancer,...
8.
Smith D, Stephenson C, Percy L, Lach A, Chatters S, Kempski H, et al.
Br J Haematol
. 2015 Apr;
171(5):881-3.
PMID: 25899469
No abstract available.